Curacel is building the largest healthcare data platform in Africa. We deliver productivity tools and IT infrastructure to healthcare stakeholders across the continent, empowering them to digitize business processes, connect with stakeholders across the spectrum, and make decisions based on data that is otherwise unavailable. Curacel’s vision is to build a connected healthcare ecosystem for low income economies, to optimize the use of scarce resources, improve patient outcomes, and inform research, policy-making and public health in Africa with 360 degree data for the first time.
54gene develops a pan-African biobank to identify new drug targets, and develop diagnostics and treatments for diseases. The company targets multiple disease states, including cancer, cardiovascular disease, and neuro-degenerative disease. It also provides genetic testing and molecular diagnostics services. The company was founded in 2019 and is based in San Francisco, California with an additional offices in Lagos, Nigeria.
54gene develops a pan-African biobank to identify new drug targets, and develop diagnostics and treatments for diseases. The company targets multiple disease states, including cancer, cardiovascular disease, and neuro-degenerative disease. It also provides genetic testing and molecular diagnostics services. The company was founded in 2019 and is based in San Francisco, California with an additional offices in Lagos, Nigeria.